Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Role of the EBMT registry on reporting CAR T-cell outcomes

Christian Chabannon, MD, PhD, Aix Marseille Université (AMU) School of Medicine, Marseille, France, outlines the role of the European Society for Blood and Marrow Transplantation (EBMT) registry on reporting on CAR T-cell outcomes. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).